Including carrier-mediated transport in oral uptake prediction of nutrients and pharmaceuticals in humans

Environmental Toxicology and Pharmacology
Isabel A O'ConnorA Jan Hendriks


Most toxicokinetic models consider passive diffusion as the only mechanism when modeling the oral uptake of chemicals. However, the overall uptake of nutrients and xenobiotics, such as pharmaceuticals and environmental pollutants, can be increased by influx transport proteins. We incorporated carrier-mediated transport into a one-compartment toxicokinetic model originally developed for passive diffusion only. The predictions were compared with measured oral uptake efficiencies of nutrients and pharmaceuticals, i.e. the fraction of the chemical reaching systemic circulation. Including carrier-mediated uptake improved model predictions for hydrophilic nutrients (RMSE=10% vs. 56%, Coefficient of Efficiency CoE=0.5 vs. -9.6) and for pharmaceuticals (RMSE=21% vs. 28% and CoE=-0.4 vs. -1.1). However, the negative CoE for pharmaceuticals indicates that further improvements are needed. Most important in this respect is a more accurate estimation of vMAX and KM as well as the determination of the amount of expressed and functional transport proteins both in vivo and in vitro.


Jan 1, 1991·European Journal of Clinical Pharmacology·T M GarriguesL F Prescott
Jul 1, 1989·British Journal of Clinical Pharmacology·D R RobertsonC F George
Aug 15, 1998·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·L X Yu, G L Amidon
Jul 19, 2002·Annales de dermatologie et de vénéréologie·B Lebrun-Vignes
Jul 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Phillip M Gerk, Mary Vore
May 17, 2003·The Journal of Pharmacology and Experimental Therapeutics·Christopher P LandowskiGordon L Amidon
Aug 6, 2004·Current Opinion in Clinical Nutrition and Metabolic Care·Alida Melse-BoonstraClive West
Oct 30, 2004·Environmental Toxicology and Chemistry·Jon A Arnot, Frank A P C Gobas
Dec 1, 2004·Clinical Pharmacokinetics·Jasper Dingemanse, Paul L M van Giersbergen
Dec 24, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Cuiping ChenTeresa A Smolarek
Apr 22, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xingguo ChengCurtis D Klaassen
Jan 18, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Liyue HuangScott Grimm
Apr 10, 2007·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Holger FischerFrank Senner
Jun 30, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Mingyan ZhouJoanne Wang
Jan 16, 2008·Physiological Reviews·Stefan Bröer
Mar 1, 2008·Nature Reviews. Drug Discovery·Paul D Dobson, Douglas B Kell
Jul 12, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Satoshi KitamuraYuichi Sugiyama
Feb 24, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Erik PacyniakGrace L Guo
Jun 5, 2010·Advances in Physiology Education·Barbara E Goodman
Jul 31, 2010·Nature Reviews. Drug Discovery·Kiyohiko SuganoFrank Senner
Mar 8, 2011·Advances in Colloid and Interface Science·P J Wilde, B S Chu
Jul 14, 2011·The Biochemical Journal·Hamid M Said
Aug 10, 2011·Advanced Drug Delivery Reviews·Ikumi Tamai
Sep 3, 2011·Toxicology and Applied Pharmacology·Erik PacyniakGrace L Guo
Sep 1, 2012·Current Drug Metabolism·Edwin C Y Chow, K Sandy Pang
Nov 14, 2012·Toxicology and Applied Pharmacology·Isabel A O'ConnorA Jan Hendriks
Apr 23, 2014·The AAPS Journal·Bhagwat Prasad, Jashvant D Unadkat

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.